In conclusion, fibroblasts, smooth muscle cells, endothelial cells, and myofibroblasts may be involved in the development of CTEPH via the circ_0026692/circ_0021630–miR-20b-5p–APP regulatory axis. The gene discussed is APP; the disease is chronic thromboembolic pulmonary hypertension.